Chapter five -428 Thresholds or 'How Much Is Too Much?, Madsen CB, Crevel RWR ,
Risk Management for Food Allergy, vol.430, pp.77-99, 2014. ,
Hazard characterisation in 432 food allergen risk assessment: The application of statistical approaches and the use of 433 clinical data, Food and Chemical Toxicology, vol.45, pp.691-701, 2007. ,
, , p.435
Factors affecting the determination 437 of threshold doses for allergenic foods: how much is too much?, J Allergy Clin Immunol, vol.438, pp.24-30, 2002. ,
Risk assessment and food 440 allergy: the probabilistic model applied to allergens, Food and Chemical Toxicology, vol.441, pp.49-54, 2007. ,
, , p.443
Approaches to risk assessment in food 444 allergy: report from a workshop ''developing a framework for assessing the risk from 445 allergenic foods, Food Chem Toxicol, vol.47, pp.480-489, 2009. ,
, , p.447
, Assessment Relating to Adventitious Presence of Allergens in Food: A Probabilistic 448 Model Applied to Peanut in Chocolate, Risk Analysis, vol.30, pp.7-19, 2010.
Translating reference doses into allergen 451 management practice: Challenges for stakeholders, Food and Chemical Toxicology, vol.452, pp.277-87, 2014. ,
, , p.454
Establishment of Reference Doses for residues of allergenic 455 foods: Report of the VITAL Expert Panel, Food and Chemical Toxicology, vol.63, pp.9-456, 2014. ,
, , p.458
Modified oral food 459 challenge used with sensitization biomarkers provides more real-life clinical thresholds 460 for peanut allergy, Journal of Allergy and Clinical Immunology, vol.461, p.10, 2014. ,
,
A EuroPrevall review of factors affecting incidence of 463 peanut allergy: priorities for research and policy, Allergy, vol.63, p.11, 2008. ,
, , p.465
Development and evolution of risk assessment for food 466 allergens, Food and Chemical Toxicology, vol.67, p.12, 2014. ,
Does severity of low-dose, double-blind, placebo-controlled food 469 challenges reflect severity of allergic reactions to peanut in the community?, Clin Exp, vol.470, pp.1227-1260, 2005. ,
The eliciting 474 dose of peanut in double-blind, placebo-controlled food challenges decreases with 475 increasing age and specific IgE level in children and young adults, Toxicology and 472 Applied Pharmacology, vol.207, p.15, 2005. ,
MIRABEL: an integrated 479 project for risk and cost/benefit analysis of peanut allergy. Regulatory Toxicology and 480, Pharmacology, vol.71, p.16, 2015. ,
, , p.482
Allergie à l'arachide en 483 France : premiers résultats de l'étude pilote du programme MIRABEL : « Approche 484 intégrée pour l'évaluation du risque et des coûts/bénéfices liés aux allergènes 485 alimentaires ». Revue Française d, Allergologie, vol.52, p.17, 2012. ,
, , p.487
Peanut allergic patients 488 in the MIRABEL survey: comorbidities and specificities of eliciting dose in real-life, Clinical and experimental allergy, vol.489, p.18, 2016. ,
study-491 group M, Two severe peanut-allergy phenotypes with gender difference: Evidence from 492 the MIRABEL survey, Clinical and Experimental Allergy, vol.46, p.19, 2016. ,
Oral food challenge 494 in children: who, when, and how? Procedures Revue Française d'Allergologie et 495 d, Immunologie Clinique, vol.46, pp.659-69, 2006. ,
Oral food challenge in children: 497 who, when, and how? Interpretation. Revue Française d'Allergologie et d'Immunologie 498, Clinique, vol.46, pp.470-74, 2006. ,
Applied Survival Analysis: Regression 500 Modeling of Time to Event Data, vol.501, p.22, 2008. ,
Regression Models and Life Tables (with Discussion), Journal of the Royal 502 Statistical Society, Series B, vol.34, p.23, 1972. ,
The BUGS project: Evolution, critique 504 and future directions, Statistics in Medicine, vol.28, p.24, 2009. ,
Distinct 506 parameters of the basophil activation test reflect the severity and threshold of allergic 507 reactions to peanut, Journal of Allergy and Clinical Immunology, vol.135, p.25, 2015. ,
, , p.509
Predicting reactivity threshold in 510 children with anaphylaxis to peanut, Clinical & Experimental Allergy, vol.512, p.26, 2017. ,
, , p.513
Self-reported adverse food reactions and anaphylaxis in the 514 SchoolNuts study: A population-based study of adolescents, Clinical Immunology, vol.141, p.27, 2018. ,
, , p.517
, , p.518
, A 519 Novel Immunoassay Using Recombinant Allergens Simplifies Peanut Allergy, p.520
, Diagnosis. International Archives of Allergy and Immunology, vol.154, pp.216-242, 2011.